Discover 575 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 575
Active & Responsive
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Tumor,
Location: Oklahoma City OK, Warrenville IL, Scottsdale AZ,
Sponsor: Proton Collaborative Group
Sex: Female
Age: 50+
Code: NCT01766297
Phase2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Oklahoma City OK, Wichita Falls TX, Denison TX,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Location: Oklahoma City OK, Tulsa OK, Plano TX, Dallas TX,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06526195
Recruiting
Active & Responsive
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
for
Healthy
Location: Oklahoma City OK, Springfield MO, Kansas City MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 12 - 30
Code: NCT06655324
Phase1, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Oklahoma City OK, Chickasha OK, McKinney TX,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
for
Type II Diabetes Mellitus
Location: Oklahoma City OK, El Dorado KS, Newton KS,
Sponsor: Sun Pharmaceutical Industries Limited
Sex: All
Age: 18+
Code: NCT07282743
Phase2, Recruiting
Active & Responsive
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Oklahoma City OK, Chickasha OK, Tulsa OK, Frisco TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05995964
Phase2, Recruiting
Active & Responsive
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
for
Alzheimer Disease
Location: Oklahoma City OK, Irving TX, DeSoto TX, Austin TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT06585787
Phase3, Recruiting
Active & Responsive
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for
Schizophrenia
Location: Oklahoma City OK, Bryant AR, Richmond TX, Houston TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07379827
Recruiting
Active & Responsive
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
for
Insomnia
Location: Oklahoma City OK, DeSoto TX, Houston TX, Savannah GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70
Code: NCT06655883
Phase3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Oklahoma City OK, Topeka KS, Little Rock AR,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
for
Lupus Nephritis
Location: Oklahoma City OK, Fort Worth TX, Atlanta GA,
Sponsor: NephroNet, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07225387
Recruiting
Active & Responsive
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
for
Systemic Lupus Erythematosus
Location: Oklahoma City OK, Atlanta GA, San Diego CA, Hershey PA,
Sponsor: NYU Langone Health
Sex: All
Age: 55+
Code: NCT05799378
Phase3, Recruiting
Active & Responsive
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Location: Oklahoma City OK, Dallas TX, Fort Worth TX,
Sponsor: Chris Goss
Sex: All
Age: 6+
Code: NCT05548283
Recruiting
Active & Responsive
The Artisseâ„¢ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
for
Intracranial Aneurysm
Location: Oklahoma City OK, Memphis TN, Englewood CO,
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 18 - 70+
Code: NCT02998229
Recruiting
Active & Responsive
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Oklahoma City OK, Dallas TX, Jackson MS, Aurora CO,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07100990
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Oklahoma City OK, Springdale AR, Fayetteville AR,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Oklahoma City OK, Bellevue NE, Omaha NE, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Oklahoma City OK, Lawton OK, Salina KS, Hays KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase2, Phase3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Oklahoma City OK, Little Rock AR, Bellevue NE, Omaha NE,